Culture, Genital
Chronic Lymphocytic Leukemia (CLL) Monitoring, MRD Detection, Bone Marrow
Ataxia Telangiectasia Mutated (ATM)
ATN1 (Atrophin 1) Gene Mutation Analysis
Hereditary Dilated Cardiomyopathy Gene Mutation Panel, NGS
Dipyridamole, Serum
Myelin Oligodendrocyte Glycoprotein (MOG), Antibody, Serum
Beta-Hydroxybutyrate, Serum
Culture, Eye (Routine)
Biopsy, Cervical
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
LOINC
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...